tirzepatide bimagrumab A drug called apitegromab may help to preserve lean body mass during weight loss with tirzepatide, a GLP-1 receptor agonist, according to a phase 2 clinical trial published in Nature Medicine. The Lilly withdraws phase 2 obesity

The hormone-balancing effect contributes to the metabolic benefits observed independent of weight loss alone

As of mid-2026, no generic versions of semaglutide or tirzepatide are FDA-approved

From the comfort and privacy of your own home, you can connect with your doctor whenever you need to, with same-day appointments 24/7, even on holidays

adults reported taking a GLP-1 drug, with about 38% of those (about 2.3% total) taking the drug to address excess weight (Montero et al., 2024)

Your provider and pharmacy should give you guidance on the right insulin needle for your treatment

It also improves skin health and promotes overall wellness